These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 28403216)
1. Efficacy and safety of aspirin in patients with peripheral vascular disease: An updated systematic review and meta-analysis of randomized controlled trials. Mahmoud AN; Elgendy AY; Rambarat C; Mahtta D; Elgendy IY; Bavry AA PLoS One; 2017; 12(4):e0175283. PubMed ID: 28403216 [TBL] [Abstract][Full Text] [Related]
2. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415 [TBL] [Abstract][Full Text] [Related]
3. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. Berger JS; Krantz MJ; Kittelson JM; Hiatt WR JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018 [TBL] [Abstract][Full Text] [Related]
4. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials. Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451 [TBL] [Abstract][Full Text] [Related]
5. Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis. Wang M; Yu H; Li Z; Gong D; Liu X Am J Cardiovasc Drugs; 2022 Nov; 22(6):657-675. PubMed ID: 35570250 [TBL] [Abstract][Full Text] [Related]
6. A Meta-Analysis of Aspirin for the Primary Prevention of Cardiovascular Diseases in the Context of Contemporary Preventive Strategies. Shah R; Khan B; Latham SB; Khan SA; Rao SV Am J Med; 2019 Nov; 132(11):1295-1304.e3. PubMed ID: 31153866 [TBL] [Abstract][Full Text] [Related]
7. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466 [TBL] [Abstract][Full Text] [Related]
8. Aspirin for Primary Prevention of Cardiovascular Events. Abdelaziz HK; Saad M; Pothineni NVK; Megaly M; Potluri R; Saleh M; Kon DLC; Roberts DH; Bhatt DL; Aronow HD; Abbott JD; Mehta JL J Am Coll Cardiol; 2019 Jun; 73(23):2915-2929. PubMed ID: 31196447 [TBL] [Abstract][Full Text] [Related]
9. Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis. Lee M; Saver JL; Hong KS; Wu HC; Ovbiagele B Circ Heart Fail; 2013 Mar; 6(2):287-92. PubMed ID: 23264446 [TBL] [Abstract][Full Text] [Related]
10. Effect of aspirin on mortality in the primary prevention of cardiovascular disease. Raju N; Sobieraj-Teague M; Hirsh J; O'Donnell M; Eikelboom J Am J Med; 2011 Jul; 124(7):621-9. PubMed ID: 21592450 [TBL] [Abstract][Full Text] [Related]
11. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis. Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900 [TBL] [Abstract][Full Text] [Related]
12. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack]. Yang C; Qian J; Tang X; Gao P; Hu Y Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406 [TBL] [Abstract][Full Text] [Related]
13. A comparison of contemporary versus older studies of aspirin for primary prevention. Moriarty F; Ebell MH Fam Pract; 2020 Jul; 37(3):290-296. PubMed ID: 31751455 [TBL] [Abstract][Full Text] [Related]
14. Validity of composite outcomes in meta-analyses of stroke prevention trials: the case of aspirin. McGrath E; O'Conghaile A; Eikelboom JW; Dinneen SF; Oczkowski C; O'Donnell MJ Cerebrovasc Dis; 2011; 32(1):22-7. PubMed ID: 21576939 [TBL] [Abstract][Full Text] [Related]
15. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis. Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632 [TBL] [Abstract][Full Text] [Related]
16. Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups. Gelbenegger G; Postula M; Pecen L; Halvorsen S; Lesiak M; Schoergenhofer C; Jilma B; Hengstenberg C; Siller-Matula JM BMC Med; 2019 Nov; 17(1):198. PubMed ID: 31679516 [TBL] [Abstract][Full Text] [Related]
17. Acetylsalicylic Acid (Aspirin) for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Liu S; Eckstein J; Lam A; Cheema AN Curr Vasc Pharmacol; 2023; 21(2):111-119. PubMed ID: 36718966 [TBL] [Abstract][Full Text] [Related]
18. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549 [TBL] [Abstract][Full Text] [Related]
19. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials. Kumar G; Goyal MK J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1279-87. PubMed ID: 23182364 [TBL] [Abstract][Full Text] [Related]